Holen Sie sich die Stockscreener-App
0.00
100.00%
-0.0002
Finanzdaten der Effector Therapeutics Inc-Aktie (EFTR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
2.35%
8.396
|
8.598 | 7.855 | 7.855 | 9.536 |
| Interest Income/Expense |
1.19%
0.749
|
0.758 | 0.75 | 0.722 | 0.689 |
| Depreciation and Amortization |
99.97%
0.028
|
110.92 | 0.026 | 0.027 | 0.028 |
| Operating Income/Loss |
2.35%
-8.396
|
-8.598 | -7.855 | -7.855 | -9.536 |
| Nonoperating Income/Loss |
17.67%
-0.438
|
-0.532 | -0.448 | -0.509 | -0.478 |
| Income/Loss From Continuing Operations Before Tax |
3.24%
-8.834
|
-9.13 | -8.303 | -8.364 | -10.01 |
| Income/Loss From Continuing Operations After Tax |
3.24%
-8.834
|
-9.13 | -8.303 | -8.364 | -10.01 |
|
Net Income/Loss
|
3.24%
-8.834
|
-9.13 | -8.303 | -8.364 | -10.01 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
108.43%
4.0816
|
-48.42 | 61.77 | 47.83 | 42.00 |
| Diluted Average Shares |
108.43%
4.0816
|
-48.42 | 61.77 | 47.83 | 42.00 |
| Basic Earnings Per Share |
86.36%
-2.16
|
-15.84 | -0.13 | -0.17 | -0.24 |
| Diluted Earnings Per Share |
86.36%
-2.16
|
-15.84 | -0.13 | -0.17 | -0.24 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.91%
1.17%
Kapitalisierung:
|
Volumen (24h):